Skip to main content
Arizona Watch· Daily Pulse

Arizona Has $1.2 Billion for Opioid Recovery and No Law Letting Pharmacists Prescribe the Medication

The state's opioid settlement money and a $20 million AHCCCS grant are real. So is the fact that Arizona isn't one of the ten states that lets a pharmacist start someone on buprenorphine.

ByThe Rize NewsroomJuly 18, 20262 min readOpioids

Under the One Arizona Agreement, the state is on track to receive up to $1.215 billion in opioid settlement money over 18 years — 44% to the state, 56% split across counties and cities. Separately, AHCCCS administers a federal HHS grant of more than $20 million aimed squarely at the populations Arizona’s opioid crisis hits hardest: people in rural counties, veterans, pregnant women, people experiencing homelessness, tribal communities, and people re-entering after incarceration. On paper, Arizona is not short on money for this fight.

Money was never the part of this crisis Arizona was short on. Permission was.

That’s the piece that doesn’t show up in a press release about settlement dollars. As we reported today, a new federal law lets pharmacists prescribe buprenorphine — the medication that treats opioid use disorder — directly to patients, if the pharmacist’s home state has passed a scope-of-practice law authorizing it. Per the National Association of Boards of Pharmacy’s tracking, about ten states have done that so far: California, Colorado, Idaho, Massachusetts, New Mexico, North Carolina, Ohio, Oregon, Pennsylvania, Washington. Arizona is not among them.

Picture what that means on the ground, not in a settlement ledger. A pharmacy in Show Low, or Sells, or Ajo is often the only licensed medical storefront within an hour’s drive. If a pharmacist there could legally hand someone the first dose of buprenorphine the same day that person walked in ready to start, some fraction of the gap between “asking for help” and “actually getting a prescription” — a gap that, for opioid withdrawal, can be measured in hours, not weeks — closes on the spot. Right now it doesn’t, because state law doesn’t allow it, and no amount of settlement money changes what the Arizona legislature or the state Board of Pharmacy hasn’t voted on.

This is a solvable problem, and it’s solvable without a dollar of new spending — it’s a scope-of-practice statute, not a budget line. Arizona already has the settlement infrastructure, the AHCCCS grant staff, and the rural population that needs exactly this fix. What it’s missing is the vote. If you’re a provider or case manager reading this, the actionable move this week is small: ask your regional AHCCCS liaison whether pharmacist MOUD authorization is on any current legislative agenda, and if it isn’t, that’s worth raising at your next team meeting — not as a hypothetical, but as the specific statute language the other ten states already passed.

Every one of those ten states had to decide, at some point, that this was worth doing. Arizona hasn’t yet. The settlement money will keep arriving either way.

Filed Under

policytreatmentArizonaOpioid Settlement

Keep up with the reporting.

One email each morning with the stories that put days like this in context.

A daily, no-spam briefing. Unsubscribe anytime.

Continue reading

More from this section